PharMetrics Showcased at Fall Forum on Anonymous Patient-Level Data & Analysis; Company Officials Present Case Study and Participate in Panel Discussion.Business Editors/Health/Medical Writers BIOWIRE2K WATERTOWN, Mass.--(BUSINESS WIRE)--Nov. 19, 2003 PharMetrics Inc. (www.pharmetrics.com), a leading provider of healthcare market intelligence solutions and analytic an·a·lyt·ic or an·a·lyt·i·cal adj. 1. Of or relating to analysis or analytics. 2. Expert in or using analysis, especially one who thinks in a logical manner. 3. Psychoanalytic. insights to the pharmaceutical industry, today announced that company officials presented a case study and participated in a panel discussion at the recently completed Fall Forum on Anonymous Patient-Level Data & Analysis, which was held in Philadelphia. Sponsored by the Centers for Business Intelligence, the Fall Forum on Anonymous Patient-Level Data and Analysis offers a perspective on issues surrounding the utilization of anonymous patient-level data, a promising tool that can provide reliable and integrated insights, which marketing executives can use to better inform their strategic decisions. Daniel W. Paterson, Vice President of Marketing and Corporate Development for PharMetrics, and, Gerald Gallivan, member of the PharMetrics Board of Directors, former Senior Vice President (ret.) at Merck & Co, and Partner at Mediphase Venture Partners, presented a case study using insights from the company's Anonymous Patient-Centric Database. The presentation, entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: , 'Leverage Anonymous Patient-Level Data to Increase the Market Potential of Your Drug,' provided illustrations from the statin stat·in n. Any of a class of drugs that inhibit a key enzyme involved in the synthesis of cholesterol and promote receptor binding of LDL cholesterol, resulting in decreased levels of serum cholesterol. market. In addition, Mr. Paterson participated in a panel discussion entitled, 'Sources and Applications of Anonymous Patient Level Data and Anonymous Patient-Centric Data - Differences, Commonalities, and Limitations of Both Data Types.' "The Fall Forum on Anonymous Patient-Level Data & Analysis is an excellent venue for communicating directly with the decision-making professionals in pharmaceutical marketing," said Michael Weintraub, President and Chief Executive Officer of PharMetrics. "Our participation at this venue and at an identical conference this past summer enabled us to demonstrate to pharmaceutical marketers how our market intelligence solutions provide them with the insight necessary to make critical strategic decisions. We look forward to continuing to expand our presence in this arena over the coming months." PharMetrics' Anonymous Patient-Centric Database is an industry-leading health insurance claims database capturing the healthcare experiences of approximately 57 million Americans. Over seventy geographically diverse health plans are contributing longitudinal lon·gi·tu·di·nal adj. Running in the direction of the long axis of the body or any of its parts. data to the Anonymous Patient-Centric Database, which now contains over 2 billion health care transactions, including prescriptions, diagnoses, outpatient outpatient /out·pa·tient/ (-pa-shent) a patient who comes to the hospital, clinic, or dispensary for diagnosis and/or treatment but does not occupy a bed. out·pa·tient n. visits, hospital stays, and diagnostic tests. This diverse set of continuously updated data is being refreshed re·fresh v. re·freshed, re·fresh·ing, re·fresh·es v.tr. 1. To revive with or as if with rest, food, or drink; give new vigor or spirit to. 2. on a monthly and quarterly basis. About PharMetrics Based in Watertown, Mass., PharMetrics is a leading provider of market intelligence solutions to the pharmaceutical, biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. , medical device, and health plan sectors of the market utilizing anonymous patient-centric data. PharMetrics strictly adheres to the requirements of the Health Insurance Portability and Accountability Act The Health Insurance Portability and Accountability Act (HIPAA) was enacted by the U.S. Congress in 1996. According to the Centers for Medicare and Medicaid Services (CMS) website, Title I of HIPAA protects health insurance coverage for workers and their families when (HIPAA (Health Insurance Portability & Accountability Act of 1996, Public Law 104-191) Also known as the "Kennedy-Kassebaum Act," this U.S. law protects employees' health insurance coverage when they change or lose their jobs (Title I) and provides standards for patient health, ), only accepting 'encrypted' (anonymous) data from its network of 70 managed care organizations around the country who have removed all individually identifiable health information such as patient names, addresses and phone numbers, and dates of birth from their data. In exchange for the data, PharMetrics provides the payor organizations with focused analyses and normative nor·ma·tive adj. Of, relating to, or prescribing a norm or standard: normative grammar. nor products that enable them to improve the efficiency of their members' use of pharmaceuticals and other services as well as the quality of the care that they provide to all of their members. For more information about PharMetrics, visit www.pharmetrics.com, email info@pharmetrics.com or call 800-783-6362. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion